Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Haemonetics (HAE) Accumulated Depreciation & Amortization (2017 - 2025)

Haemonetics (HAE) has 15 years of Accumulated Depreciation & Amortization data on record, last reported at $522.8 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $522.8 million; the TTM value through Sep 2025 reached $522.8 million, changed N/A, while the annual FY2025 figure was $553.1 million, 14.61% down from the prior year.
  • Accumulated Depreciation & Amortization reached $522.8 million in Q3 2025 per HAE's latest filing, up from $508.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $660.6 million in Q4 2023 and bottomed at $508.2 million in Q2 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $602.5 million, with a median of $622.0 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 3.71% in 2023, then fell 21.39% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $599.7 million in 2021, then rose by 1.83% to $610.7 million in 2022, then increased by 8.18% to $660.6 million in 2023, then decreased by 2.13% to $646.6 million in 2024, then fell by 19.14% to $522.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $522.8 million in Q3 2025, $508.2 million in Q2 2025, and $553.1 million in Q1 2025.